SURGICAL OUTCOME OF CONGENITAL HEART DEFECTS WITH PULMONARY HYPERTENSION IN INFANTS
Keywords:
bypass, pulmonary hypertension, infantsAbstract
Background: Congenital heart diseases with large left-to-right shunt often have signs of pulmonary artery hypertension. It is an important determinant of morbidity and mortality in patients without educate surgical treatment especially in infants.
Methods: Ninety patients with congenital cardiac septal defects and pulmonary arterial hypertension had operation to close their septal defects. All the patients have been checked by Chest X-ray, EchoCG, ECG, selectively performed the cardiac catheterization and lung biopsy. Before and after surgery the PA pressure was compared to systemic by needle puncture measurement.
Results: Twenty patients died in the hospital after operation and there were no later deaths in follow-up. Hemodynamic changes after operation included a significant decrease in pulmonary artery pressure (mean pulmonary artery pressure, 28.3± 2.4 mm Hg versus 58.45± 1.69 mm Hg before repair). The follow-up period was from 3 months to 4 years (mean 1.3 ± 0.6 years).
Conclusion: Studies from developed countries have shown that in term infants, young age is not a risk factor for adverse postoperative outcome after surgical closure of septal left-to-right defects. The data presented in this study shows that operations to close cardiac septal defects in the presence of severe pulmonary hypertension are effective, but must be done during first 6 month.
References
S.V. Gorbachevskiy- Pulmonary Hypertension in Ventricular Septal Defect.: J. Grudnya Hirurgiya. Moskow, 1990.
Arciniegas E. Ventricular septal defect. In: Glen WWL, ed. Thoracic and cardiovascular surgery. East Norwalk: Appleton-Century-Crofts, 1983:745-56.
V.I. Burakovskiy, L.A.Bokeriya- Serdechno- Sosudistaya Hirurgiya. Moskow “Medicine”, 1989.
Heath D, Edwards JE. The pathology of hypertensive pulmonary vascular disease: a description of six grades of structural changes in the pulmonary artery with special reference to congenital cardiac septal defects. Circulation 1958;18:533-47.
Hallman GL, Cooley DA, Wolfe RR, McNamara DG. Surgical treatment of ventricular septal defect associated with pulmonary hypertension. J Thorac Cardiovasc Surg 1964; 48:588-600.
Cartmail TB, Dushane JW, McGoon DC, Kirklin JW. Results of repair of ventricular septal defect. J Thorac Cardiovasc Surg 1966;52:486-9.
Friedli BG, Kidd BSL, Mustard WT, Keith JD. Ventricular septal defect with increased pulmonary vascular resistance. Am J Cardiol 1974;33:403-9.
John S, Korula R, Jairaj PS, Muralidharan S, et al. Results of surgical treatment of ventricular septal defect with pulmonary hypertension. Thorax 1983;38:279-83.
Kirklin JW, Barratt-Boyes BG. Cardiac surgery. New York: John Wiley & Sons, 1986:599.
Guo JQ, Xue GX, Zhu XD, et al. Surgical treatment of congenital ventricular septal defect: a 21 years experience in 1187 patients. Chin Med J 1983;96:323-9.
De Souza CA, Spyt TJ. Release of vasoactive substance during cardiopulmonary bypass. Ann Thorac Surg 1992;56: 397-8.
Komai H, Yamamoto F, Tanaka K, et al. Increased lung injury in pulmonary hypertensive patients during open heart operations. Ann Thorac Surg 1993;55:1147-52.
Nuttall GA, Murray MJ, Bowie EJW. Protamine-heparininduced pulmonary hypertension in pigs: effects of treatment with a thromboxane receptor antagonist on hemodynamics and coagulation. Anesthesiology 1991;74:138-45.
Montalescot G, Lowenstein E, Ogletree ML, et al. Thromboxane receptor blockade prevents pulmonary hypertension induced by heparin-protamine reactions in awake sheep. Circulation 1990;82:1765-77.
Steele PM, Ruster V, Cohen M, Ritter DG, McGoon DC. Isolated atrial septal defect with pulmonary vascular obstructive disease: long-term follow-up and prediction of outcome after surgical correction. Circulation 1987;76: 1037-42.
Kirkling/Barrat-Boyes. Cardiac Surgery, third edition, Volume II, 2003.
